RVTY Launches New Kit in Europe for Newborn Type 1 Diabetes DetectionZacks Investment Research • 09/25/26
Revvity Launches IVDR-Certified Solution for Early Detection of Type 1 DiabetesBusiness Wire • 09/24/26
Strength Seen in Revvity (RVTY): Can Its 9.1% Jump Turn into More Strength?Zacks Investment Research • 09/16/26
Revvity, Inc. (RVTY) Presents at 2026 Global Healthcare Conference TranscriptSeeking Alpha • 09/15/26
Revvity, Inc. (RVTY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/14/26
Revvity to Acquire Human Cell Design to Boost Metabolic DiscoveryZacks Investment Research • 09/11/26
Revvity, Inc. (RVTY) Presents at Wells Fargo 21st Annual Healthcare Conference Prepared Remarks TranscriptSeeking Alpha • 09/09/26
Revvity to Acquire Human Cell Design to Advance Human-Relevant Cell Models for Metabolic Disease Drug DiscoveryBusiness Wire • 09/09/26
Is Revvity Stock a Buy as Growth Improves but Valuation Stays Rich?Zacks Investment Research • 09/04/26
Revvity Launches SuperFlex Prenatal Screening System for Smaller LabsZacks Investment Research • 08/13/26
Revvity Launches SuperFlex Prenatal Screening System, Expanding Access to Preeclampsia TestingBusiness Wire • 08/10/26
RVTY Q2 Earnings Beat Estimates on Diagnostics Strength, '26 View UpZacks Investment Research • 08/04/26
Revvity Develops High-Throughput T-SPOT.TB Platform for Clinical LabsZacks Investment Research • 07/24/26
Revvity Announces Development of High-Throughput T-SPOT.TB Automated Platform for Clinical LabsBusiness Wire • 07/23/26
Revvity to Launch Signals for Startups for Emerging Biotech CompaniesZacks Investment Research • 07/22/26
Revvity Launches “Signals for Startups” to Help Emerging Biotechs Build Scalable Digital Foundations from Day OneBusiness Wire • 07/20/26